Works matching AU Antal, Joyce M.

Results: 7

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Published in:

2021

By:

Hart, Lowell L.;
Ferrarotto, Renata;
Andric, Zoran G.;
Beck, J. Thaddeus;
Subramanian, Janakiraman;
Radosavljevic, Davorin Z.;
Zaric, Bojan;
Hanna, Wahid T.;
Aljumaily, Raid;
Owonikoko, Taofeek K.;
Verhoeven, Didier;
Xiao, Jie;
Morris, Shannon R.;
Antal, Joyce M.;
Hussein, Maen A.

Publication type:

journal article

A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.

Published in:

Investigational New Drugs, 2018, v. 36, n. 6, p. 1016, doi. 10.1007/s10637-018-0591-z

By:

Aghajanian, Carol;
Bell-McGuinn, Katherine M.;
Burris, Howard A.;
Siu, Lillian L.;
Stayner, Lee-Ann;
Wheler, Jennifer J.;
Hong, David S.;
Kurkjian, Carla;
Pant, Shubham;
Santiago-Walker, Ademi;
Gauvin, Jennifer L.;
Antal, Joyce M.;
Opalinska, Joanna B.;
Morris, Shannon R.;
Infante, Jeffrey R.

Publication type:

Article

Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist.

Published in:

Investigational New Drugs, 2012, v. 30, n. 2, p. 662, doi. 10.1007/s10637-010-9604-2

By:

Bauman, John W.;
Antal, Joyce M.;
Adams, Laurel M.;
Johnson, Brendan M.;
Murray, Sharon C.;
Peng, Bin;
Kirby, Lyndon C.;
Lebowitz, Peter F.;
Marbury, Thomas C.;
Swan, Suzanne;
Gutierrez, Maria

Publication type:

Article

Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 5, p. 449, doi. 10.1016/j.cllc.2021.03.010

By:

Weiss, Jared;
Goldschmidt, Jerome;
Andric, Zoran;
Dragnev, Konstantin H.;
Gwaltney, Chad;
Skaltsa, Konstantina;
Pritchett, Yili;
Antal, Joyce M.;
Morris, Shannon R.;
Daniel, Davey

Publication type:

Article

Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.

Published in:

Cancer Management & Research, 2021, v. 13, p. 6207, doi. 10.2147/CMAR.S313045

By:

Hussein, Maen;
Maglakelidze, Marina;
Richards, Donald A;
Sabatini, Marielle;
Gersten, Todd A;
Lerro, Keith;
Sinielnikov, Ivan;
Spira, Alexander;
Pritchett, Yili;
Antal, Joyce M;
Malik, Rajesh;
Beck, J Thaddeus

Publication type:

Article

Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP-1 Cells and Murine Microglia.

Published in:

Journal of Neurochemistry, 2000, v. 74, n. 3, p. 1017, doi. 10.1046/j.1471-4159.2000.0741017.x

By:

Yates, Stephen L.;
Burgess, Loyd H.;
Kocsis-Angle, June;
Antal, Joyce M.;
Dority, Michael D.;
Embury, Paula B.;
Piotrkowski, Anthony M.;
Brunden, Kurt R.

Publication type:

Article

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.

Published in:

International Journal of Cancer, 2021, v. 148, n. 10, p. 2557, doi. 10.1002/ijc.33453

By:

Daniel, Davey;
Kuchava, Vladimer;
Bondarenko, Igor;
Ivashchuk, Oleksandr;
Reddy, Sreekanth;
Jaal, Jana;
Kudaba, Iveta;
Hart, Lowell;
Matitashvili, Amiran;
Pritchett, Yili;
Morris, Shannon R.;
Sorrentino, Jessica A.;
Antal, Joyce M.;
Goldschmidt, Jerome

Publication type:

Article